ZFIN ID: ZDB-FISH-150901-29307
Fish name: mi2001Tg
Genotype: mi2001Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by mi2001Tg
No data available
GENE EXPRESSION
Gene expression in mi2001Tg
RNA expression
Expressed Gene Structure Conditions Figures
apoea standard conditions Fig. 5 with image from Raymond et al., 2006
atf4b control Fig. 5 from Samarut et al., 2016
atf7a control Fig. 5 from Samarut et al., 2016
atf7ip control Fig. 5 from Samarut et al., 2016
atp1a2a standard conditions Fig. 5 with image from Doganli et al., 2012
bmp2b control Fig. 5 from Samarut et al., 2016
bmp6 control Fig. 5 from Samarut et al., 2016
cacna2d4b control Fig. 5 from Samarut et al., 2016
calb2b standard conditions Fig. 3 with imageFig. 4 with image from Bernardos et al., 2006
camk4 control Fig. 5 from Samarut et al., 2016
crx chemical treatment: 5-bromo-2'-deoxyuridine Fig. 4 from Bernardos et al., 2007
dkk1b control Fig. 5 from Samarut et al., 2016
fosl1a control Fig. 5 from Samarut et al., 2016
fzd10 standard conditions Fig. 2 from Shitasako et al., 2017
gfap standard conditions Fig. 5 with image from Doganli et al., 2012
Fig. S1 with image from Alvarez et al., 2007
Fig. 2 with imageFig. 3 with imageFig. 4 with image from Bernardos et al., 2006
her4.1 control Fig. 2 from Bekri et al., 2019
itpr1b control Fig. 5 from Samarut et al., 2016
lgals2a light damage Fig. 3 from Craig et al., 2010
lnx1 control Fig. 1 from Bekri et al., 2019
mcm5 control Fig. 1 with imageFig. 2 with image from Katz et al., 2016
Fig. 2 with imageFig. 4 with image from Alunni et al., 2013
chemical treatment: LY-411575 Fig. 2 with image from Alunni et al., 2013
mdka standard conditions Fig. 4 from Calinescu et al., 2009
mir9-6 standard conditions Fig. 1 with imageFig. 4 with image from Katz et al., 2016
notch1b control Fig. 4 with image from Alunni et al., 2013
notch3 control Fig. 4 with image from Alunni et al., 2013
numbl control Fig. 2 from Bekri et al., 2019
pax2a control Figure S4 with image from Charlton-Perkins et al., 2019
pcna standard conditions Fig. 1 from Chapouton et al., 2010
light damage Fig. 3 from Craig et al., 2010
rho chemical treatment: 5-bromo-2'-deoxyuridine Fig. 4 from Bernardos et al., 2007
s100b standard conditions Fig. 1 from Chapouton et al., 2010
shhb control Fig. 5 from Samarut et al., 2016
smad3a control Fig. 5 from Samarut et al., 2016
sox2 standard conditions Fig. S8 with image from Jao et al., 2012
sox4a standard conditions Fig. S1 with image from Wen et al., 2015
sox4b standard conditions Fig. S1 with image from Wen et al., 2015
sox10 standard conditions Fig. 3 with image from Kim et al., 2008
tp53 control Fig. 5 from Samarut et al., 2016
vasnb standard conditions Fig. 6 with image from Panza et al., 2015
wif1 control Fig. 5 from Samarut et al., 2016
wnt3a standard conditions Fig. 1 from Shitasako et al., 2017
Protein expression
Antibody Antigen Genes Structure Conditions Figures
zpr-1 control Fig. 6 with image from Olena et al., 2015
Fig. 2 with image from Zou et al., 2012
Fig. 1 with image from Jing et al., 2009
Ab1-crb2a standard conditions Fig. 2 with image from Zou et al., 2012
Ab1-ago control Fig. 4 with image from Katz et al., 2016
Ab1-crb2b standard conditions Fig. 2 with image from Zou et al., 2012
Ab2-isl standard conditions Fig. 3 with image from Kim et al., 2008
zn-8 standard conditions Fig. 3 with image from Kim et al., 2008
Ab1-elavl control Fig. 6 from Duy et al., 2017
Fig. 6 with image from Olena et al., 2015
Fig. 3 with image from Alunni et al., 2013
Fig. 2 with image from Kim et al., 2008
Ab14-rps6k perforation: retina Fig. 1 from Zhang et al., 2019
zrf-1 standard conditions Fig. 1 with image from Kim et al., 2008
Ab1-fabp7 standard conditions Fig. 2 from Kim et al., 2008
Ab3-mpp5a standard conditions Fig. 7 with image from Jing et al., 2009
Ab1-tjp1 standard conditions Fig. 7 with image from Jing et al., 2009
Ab1-elavl chemical treatment: LY-411575 Fig. 6 from Duy et al., 2017
Fig. 3 with image from Alunni et al., 2013
Ab-G3G4 chemical treatment: 5-bromo-2'-deoxyuridine Fig. 2 with image from Kim et al., 2008
Ab1-mcm5 mcm5 control Fig. 5 with image from Than-Trong et al., 2018
Fig. 1 with imageFig. 2 with image from Katz et al., 2016
Ab1-pax2 pax2a control Figure S4 with image from Charlton-Perkins et al., 2019
Ab2-pcna pcna light damage Fig. 3 from Craig et al., 2010
Ab1-s100 s100b standard conditions Fig. 1 from Chapouton et al., 2010
Ab1-sox10 sox10 standard conditions Fig. 3 with image from Kim et al., 2008
PHENOTYPE
Phenotype in mi2001Tg
Phenotype Conditions Figures
dorsal telencephalon radial glial cell multipotent, normal chemical treatment: LY-411575 Fig. 3 with image from Alunni et al., 2013
dorsal telencephalon radial glial cell proliferative, abnormal chemical treatment: LY-411575 Fig. 1 with imageFig. 2 with image from Alunni et al., 2013
dorsal telencephalon ventricular zone has extra parts of type radial glial cell, abnormal chemical treatment: LY-411575 Fig. 2 with image from Alunni et al., 2013
forebrain asymmetric stem cell division increased occurrence, abnormal chemical treatment: LY-411575 Fig. 1 with image from Alunni et al., 2013
lateral zone of dorsal telencephalon gliogenesis increased occurrence, abnormal chemical treatment by environment: pentetrazol Fig. 6 from Duy et al., 2017
lateral zone of dorsal telencephalon radial glial cell proliferative, abnormal chemical treatment by environment: pentetrazol Fig. 6 from Duy et al., 2017
Notch signaling pathway decreased occurrence, abnormal chemical treatment: LY-411575 Fig. 1 with image from Alunni et al., 2013

CITATIONS  (61)